Successful use of interferon alfa-n1 in the treatment of hairy cell leukemia.
Following a report on the beneficial effects of interferon administered to patients with hairy cell leukemia, a trial was initiated to test a highly purified interferon in cytopenic hairy cell leukemia patients undeniably requiring therapy. Their response was followed with detailed immunologic surface marker studies.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000097:blood / Q000276:immunology / Q000628:therapy*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000145:classification
D007370:Interferon Type I